Furthermore, the EP4 antagonist inhibited IL-6 production and MMP-2 activation in human AAA tissues, suggesting a mechanism for EP4 antagonist-mediated inhibition of AAA formation. The gene discussed is MMP2; the disease is triple-A syndrome.